Philip Ross is Global Chairman for Healthcare in J.P. Morgan’s Investment Banking Group. As a client executive and key coverage partner, Phil is responsible for relationships with many of our clients in the biotechnology industry. Phil also leverages his biotechnology expertise for J.P. Morgan's global pharmaceutical coverage effort.
Dr. Ross joined Hambrecht & Quist’s Corporate Finance department in January 2000. Prior to joining Chase H&Q, he was an associate at CIBC World Markets. Dr. Ross is a diplomat to the American Board of Quality Assurance and Utilization Review Physicians and a Certified Public Accountant. Philip received a medical degree from the Philadelphia College of Osteopathic Medicine, an MBA from St. Joseph’s University, and a BS in management from the A.B. Freeman School of Business at Tulane University.
Dr. Ross joined Hambrecht & Quist’s Corporate Finance department in January 2000. Prior to joining Chase H&Q, he was an associate at CIBC World Markets. Dr. Ross is a diplomat to the American Board of Quality Assurance and Utilization Review Physicians and a Certified Public Accountant. Philip received a medical degree from the Philadelphia College of Osteopathic Medicine, an MBA from St. Joseph’s University, and a BS in management from the A.B. Freeman School of Business at Tulane University.
Speaking In
4:00 PM - 4:45 PM (EST)
Tuesday, February 7
Despite softening valuations among public biotechs and a major tightening of post-series B private…
South Broadway Ballroom